Probing the antigenicity of E. coli L-asparaginase by mutational analysis
- PMID: 16691007
- DOI: 10.1385/MB:33:1:57
Probing the antigenicity of E. coli L-asparaginase by mutational analysis
Abstract
A strategy, termed alanine-scanning mutagenesis, was used to identify the amino acid residues which are critical to the antigenicity of Escherichia coli L-asparaginase (L-ASP). Three continuous alkaline residues, 195RKH197, were mutated to Ala selectively. Four mutant recombinant L-ASPs were constructed and expressed in E. coli, and then purified. The purified mutants showed a single band by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and were more than 95% pure by reverse high-performance liquid chromatography. The activities of wild-type and mL-ASPs in the fermentative medium were all about 130 U/mL. The change from 195RKH197 to 195AAA197 reduced the antigenicity of the enzyme greatly as shown in competition enzyme-linked immunosorbent assay using polyclonal antibodies raised against the wild-type L-ASP from rabbits. The results show that residues 195RKH197 of E. coli L-ASP are critical to its antigenicity.
Similar articles
-
Purification of Escherichia coli L-asparaginase mutants by a native polyacrylamide gel electrophoresis.J Chromatogr Sci. 2008 Jul;46(6):556-9. doi: 10.1093/chromsci/46.6.556. J Chromatogr Sci. 2008. PMID: 18647480
-
Erwinia chrysanthemi L-asparaginase: epitope mapping and production of antigenically modified enzymes.Biochem J. 1994 Sep 15;302 ( Pt 3)(Pt 3):921-7. doi: 10.1042/bj3020921. Biochem J. 1994. PMID: 7945221 Free PMC article.
-
Probing the role of threonine and serine residues of E. coli asparaginase II by site-specific mutagenesis.Protein Eng. 1992 Dec;5(8):785-9. doi: 10.1093/protein/5.8.785. Protein Eng. 1992. PMID: 1287659
-
[Purification and properties of recombinant Erwinia carotovora L-asparaginase expressed in E.coli cells].Biomed Khim. 2003 Sep-Oct;49(5):502-7. Biomed Khim. 2003. PMID: 16119104 Russian.
-
Extracellular expression and single step purification of recombinant Escherichia coli L-asparaginase II.Protein Expr Purif. 2004 Nov;38(1):29-36. doi: 10.1016/j.pep.2004.07.009. Protein Expr Purif. 2004. PMID: 15477079
Cited by
-
Molecular Analysis of L-Asparaginases for Clarification of the Mechanism of Action and Optimization of Pharmacological Functions.Pharmaceutics. 2022 Mar 9;14(3):599. doi: 10.3390/pharmaceutics14030599. Pharmaceutics. 2022. PMID: 35335974 Free PMC article. Review.
-
Development of L-Asparaginase Biobetters: Current Research Status and Review of the Desirable Quality Profiles.Front Bioeng Biotechnol. 2019 Jan 10;6:212. doi: 10.3389/fbioe.2018.00212. eCollection 2018. Front Bioeng Biotechnol. 2019. PMID: 30687702 Free PMC article. Review.
-
Protein re-surfacing of E. coli L-Asparaginase to evade pre-existing anti-drug antibodies and hypersensitivity responses.Front Immunol. 2022 Dec 7;13:1016179. doi: 10.3389/fimmu.2022.1016179. eCollection 2022. Front Immunol. 2022. PMID: 36569945 Free PMC article.
-
Expression and Biological Evaluation of an Engineered Recombinant L-asparaginase Designed by In Silico Method Based on Sequence of the Enzyme from Escherichia coli.Adv Pharm Bull. 2023 Nov;13(4):827-836. doi: 10.34172/apb.2023.085. Epub 2023 Jun 12. Adv Pharm Bull. 2023. PMID: 38022803 Free PMC article.
-
Mutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice.J Biol Chem. 2014 Feb 7;289(6):3555-70. doi: 10.1074/jbc.M113.486530. Epub 2013 Dec 2. J Biol Chem. 2014. PMID: 24297177 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources